Aptevo Therapeutics Inc (NASDAQ:APVO) shares are trading higher on Tuesday, after the company announced it regained compliance with the NASDAQ listing requirements.
Aptevo Therapeutics is a clinical-stage biotechnology company, engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics in the U.S.
Aptevo Therapeutics shares were trading 8.24% higher at $4.07 on Tuesday. The stock has a 52-week high of $14.56 and a 52-week low of 27 cents.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
Posted In:
